Yukon Chrome PC
Asset
Sirolimus-eluting bioabsorbable polymer coronary stent system
- Stage
- Human trials
- Modality
- Device
- Target
- mTOR signalling
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Coronaropathy
Human trials, Completed, NCT03918070, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors1
Every asset’s record: target, stage, trials and the evidence behind it.